| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3283834 | Clinical Gastroenterology and Hepatology | 2011 | 9 Pages |
Abstract
The presence of MDBs in liver biopsy samples from patients with CHC is associated independently with fibrosis progression. Gain of MDBs over time is associated with decompensation and progression to cirrhosis; and occurs most frequently among diabetic patients. MDBs might be used as prognostic factors for patients with CHC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Mina O. Rakoski, Morton B. Brown, Robert J. Fontana, Herbert L. Bonkovsky, Elizabeth M. Brunt, Zachary D. Goodman, Anna S. Lok, M. Bishr Omary, HALT-C Trial Group HALT-C Trial Group,